Neurocrine Biosciences, Inc. (NBIX) Stock Overview
Explore Neurocrine Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Neurocrine Biosciences, Inc. (NBIX)
Key Financials
Key Financials
Market Cap
17.4B
P/E Ratio
26.00
EPS (TTM)
$6.92
ROE
0.22%
NBIX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Neurocrine Biosciences, Inc. (NBIX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $157.68.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.00 and a market capitalization of 17.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.